NATIONAL HEALTH INVESTORS REIT INC (NHI)
Real Estate · healthcare REITs · NYSE
National Health Investors is a specialized healthcare REIT focused on long-term investments in senior housing and medical facilities.
What NATIONAL HEALTH INVESTORS REIT INC does
National Health Investors is a real estate investment trust (REIT) that specializes in the financing and ownership of healthcare-related properties. The company maintains a portfolio that includes independent living facilities, assisted living facilities, skilled nursing facilities, and medical office buildings, primarily utilizing sale-leaseback transactions and mortgage financing.
Themes: senior housing, healthcare real estate, REITs
Fundamentals
- Price$73.36 as of 2026-08-21 close
- Market cap$3.6B as of 2026-08-21
- 1-year return-5.1% 2025-08-21 close $77.29 → 2026-08-21 close $73.36
- P/E23.73 as of 2026-08-24
- Net margin+36.9% as of 2026-08-24
- Gross margin+77.8% as of 2026-08-24
- ROE+9.9% as of 2026-08-24
- Debt / equity0.84 as of 2026-08-24
- Revenue growth (YoY)+17.1% as of 2026-08-24
- Revenue CAGR (3y)+10.5% SEC XBRL
- Beta0.52 as of 2026-08-24
- Last reported earnings2026-08-10 SEC EDGAR Form 8-K (Item 2.02)
Dividend: yield +6.6%; 2-year non-decreasing per-share dividend streak (SEC XBRL).
How NHI compares in its sector
- price-to-earnings ratiomiddle range 127 covered Real Estate peers, as of 2026-08-24
- net profit margintop 25% 161 covered Real Estate peers, as of 2026-08-24
- operating marginmiddle range 161 covered Real Estate peers, as of 2026-08-24
- gross margintop 25% 156 covered Real Estate peers, as of 2026-08-24
- return on equitytop 25% 162 covered Real Estate peers, as of 2026-08-24
- 3-year revenue CAGRtop 25% 155 covered Real Estate peers
- indicated dividend yieldmiddle range 138 covered Real Estate peers, as of 2026-08-24
- free cash flow (absolute dollars, latest fiscal year)bottom 25% 42 covered Real Estate peers, as of FY2025
Position among covered Real Estate companies that report each metric (minimum 5 peers). A relative position within our covered catalog — not a valuation, quality, or investment judgment. A higher percentile is simply a higher value (for P/E, more expensive on earnings — never "better"). Informational only.
Top 10 scores & list membership
NHI is not currently in any published Top 10 list. Its scores are below.
Long-term score
48.6 #555 of 987 scored · #57 of 84 in Real Estate
Growth 77th (revenue growth year over year 17.1%, 3-year revenue CAGR 10.5%) and valuation 62nd (price to earnings 23.7, price to book 2.4); weakest is long-term trend (18th, a strong downtrend, with sellers in control).
Short-term score
34.1 #1579 of 1,704 scored · #81 of 94 in Real Estate
Volume and participation 45th: it gapped 5.0% above the previous close and has not traded back through the level it left behind — an "unfilled gap", which describes a price range no trade has since crossed and is not a forecast that it will be crossed; setup 44th: no Elliott-wave labelling currently fits its swings; weakest is trend 25th: a strong downtrend, with sellers in control.
Scores as of 21 Aug 2026. Each bar is a percentile: how this company ranked against every company the score ranked, 0–100. A list is a published formula and its output, not a recommendation. Method version 2.
Dividend coverage (FY2025)
Exceeded at least one reported measure. In FY2025, NHI's dividend exceeded at least one reported measure of what it earned or generated (earnings payout 119%). A payout above 100% in one year is not necessarily unsustainable, but it is not fully covered by that measure.
- Earnings payout119% dividends / net income
- Free-cash-flow payoutnot assessable free cash flow was not positive that year
Coverage derived from reported SEC EDGAR XBRL figures for FY2025 (dividends paid vs. net income and free cash flow, same fiscal year). This describes PAST coverage for one fiscal year — it does not predict whether a dividend will be maintained, raised, or cut, and a one-year payout ratio can be distorted by non-recurring items. Informational only — not financial advice.
How NATIONAL HEALTH INVESTORS REIT INC looks technically
NATIONAL HEALTH INVESTORS REIT INC (NHI) is trading 6.9% below its 200-day average, the long-term trend line — a long-term downtrend. Its 50-day average crossed below its 200-day average about 55 trading days ago — a "death cross", a bearish long-term signal. A strong downtrend is in place — ADX, a 0–100 trend-strength gauge, is 32, with sellers in control. Momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 44, neither overbought (above 70) nor oversold (below 30). It made a new 20-day low about 9 trading days ago. It is 19.7% below its highest point of the past year.
Trend
8
| Distance from the 200-day | it is trading 6.9% below its 200-day average, the long-term trend line — a long-term downtrend | -6.9% |
|---|---|---|
| 50-day moving average | its average price over the last 50 trading days — a short-term trend line — is $75.37 | $75.37 |
| 200-day moving average | its average price over the last 200 trading days — the long-term trend line — is $78.77 | $78.77 |
| Swing structure | each recent peak has been higher than the one before it and each dip has been shallower — the pattern chart-watchers call an uptrend, which describes where price has already been and not where it goes next | higher highs and higher lows |
| Last swing turn | its last significant turn was a swing low 10 calendar days ago — the swings before that are what the structure reading is measured on | 10 sessions |
| Wave structure | its recent swings can be read as a five-part upward sequence — what Elliott-wave chartists call an impulse — now in leg 3 of five; the labelling fails if price closes below 69.49. It is one of several labellings that fit, and it describes the swings already printed, not what comes next. The same swings also read as a three-part correction in leg C. | possible upward five-wave sequence, in wave 3 (one of several readings) |
| Since the 50/200 cross | its 50-day average crossed below its 200-day average about 55 trading days ago — a "death cross", a bearish long-term signal | 55 sessions |
| Trend strength (14-day ADX) | a strong downtrend is in place — ADX, a 0–100 trend-strength gauge, is 32, with sellers in control | 31.8 |
Momentum
3
| 14-day RSI | momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 44, neither overbought (above 70) nor oversold (below 30) | 44.2 |
|---|---|---|
| Position in its 14-day range | it is trading in the upper half of its 14-day range ($69.49 to $75.79) — its "stochastic" reading is 61 out of 100, where 0 would mean closing exactly at the 14-session low and 100 exactly at the high. This measures WHERE the price sits inside its recent range, which is a different question from the RSI beside it: RSI is a momentum gauge, measuring how FAST the price has been moving, so a stock can drift quietly to the bottom of its range with an ordinary RSI, or fall sharply and still sit in the middle. It has been climbing within that range over the last few sessions. | 61.4 |
| Since the MACD crossed zero | MACD, a trend-momentum gauge, is in negative territory (momentum leaning bearish) | 18 sessions |
Range
12
| 52-week high | its highest closing price over the past year (about 252 trading days) was $91.38 | $91.38 |
|---|---|---|
| From the 52-week high | it is 19.7% below its 52-week high (its highest price of the past year) | -19.7% |
| Above the 52-week low | it is 8.0% above its 52-week low (its lowest price of the past year) | +8.0% |
| Below the 52-week high | it is 19.7% below its highest point of the past year | 19.7% |
| Since a 20-day breakout | it made a new 20-day low about 9 trading days ago | 9 sessions |
| Since a 55-day breakout | it made a new 55-day high about 24 trading days ago | 24 sessions |
| All-time high | its highest closing price on record is $91.38 (set on 2026-02-17) | $91.38 |
| Given back of the 52-week move | over the past year its closes ranged ($68.32 to $91.02), and it has recovered roughly a quarter of its fall from last year’s high — 22% of it. Chart-watchers call 61.8%-65% given back the "golden pocket" — for this company that is $82.35 to $83.08. It is watched widely enough that orders cluster there, which is the honest reason it matters; it is not a forecast. | 22.2% |
| From the all-time high | it is 19.7% below its all-time high | -19.7% |
| Nearest price level | it is trading 0.9% above a support level at $72.71 — a price it turned at 7 times since 2025-03-25, most recently on 2026-06-11. Since 2024-08-21 it has 5 such levels below the current price and 6 above. Levels like these describe where the price has reversed or paused before; they are not a forecast of where it will go. | -0.9% |
| All-time low | its lowest closing price on record is $17.10 (set on 2008-11-21) | $17.10 |
| Above the all-time low | it is 329.0% above its all-time low | +329.0% |
Volatility
5
| Band width vs its own 6 months | day-to-day price swings are about average versus its own recent 6-month history | 56th percentile |
|---|---|---|
| Typical daily range | in a typical session it travels about $1.80 between its high and its low — about 2.5% of its price. That is its "average true range" over the last 14 sessions, which also counts the distance from the previous close, so a day that opens well away from yesterday counts as the large move it was | $1.80 |
| Bollinger bands (20-day, ±2σ) | most of its recent trading has stayed between about $69.77 and $79.44 — the "Bollinger bands", a range drawn two standard deviations either side of its 20-day average price, which widens when the stock gets more volatile and narrows when it settles | $69.77 – $74.61 – $79.44 |
| Typical daily range (% of price) | its price moves about 2.5% in a typical session — calmer than most companies we cover. This is the average gap between a session's high and low over the last 14 sessions, counting overnight moves, expressed against the current price so it can be compared with companies trading at any price | 2.5% |
| Stretch from the 200-day average | it is trading 3.0 daily ranges below its 200-day average price (6.9% below it in plain percentage terms) — a way of asking how far it has stretched from its own average in units of how far it normally moves in a day, so a calm company and a jumpy one can be compared on the same scale | 3.0 daily ranges below its 200-day average |
Volume
1
| Volume vs its 30-day average | trading volume is about normal versus its 30-day average | 0.64× |
|---|
Analyst
2
| Change in the average price target | analysts have cut their average price target by 0.9% since the prior reading | -0.9% |
|---|---|---|
| Change in the consensus rating | the analyst consensus rating is unchanged since the prior reading | unchanged |
Candlestick patterns
1
| Since a doji | 6 sessions ago it opened and closed at almost the same price after trading through a wider range — a "doji", the classic picture of buyers and sellers finishing the session level | 6 sessions ago |
|---|
Price gaps
3
| Gap at the open | it opened on 2026-08-21 0.2% above the previous session's close — an overnight gap, the part of the move that happened while the market was shut, and traded back through that level before the close | +0.1% |
|---|---|---|
| Open gap | it gapped 5.0% above the previous close 48 sessions ago and has not traded back through the level it left behind at 69.43 — an "unfilled gap", which describes a price range no trade has since crossed and is not a forecast that it will be crossed | +5.0% |
| Gap filled | a 4.1% gap up opened on 2026-06-24 has been "filled" 12 sessions ago — price traded back through the level the gap left behind, and it took 29 sessions to close | 12 sessions ago |
Price streaks
1
| Closing streak | it has closed lower 2 sessions in a row, a -0.97% move over the run — an unbroken run of down days, which describes what has already happened and says nothing about the next session | 2 sessions down |
|---|
Relative strength
4
| vs market, 1 month | over the past 1 month this stock lagged the market by 11.9 percentage points (the stock lost 9.5% while the market gained 2.3%) | -11.9% |
|---|---|---|
| vs market, 3 months | over the past 3 months this stock lagged the market by 7.3 percentage points (the stock lost 4.2% while the market gained 3.1%) | -7.3% |
| vs market, 6 months | over the past 6 months this stock lagged the market by 28.4 percentage points (the stock lost 17.3% while the market gained 11.1%) | -28.4% |
| vs market, 12 months | over the past 12 months this stock lagged the market by 25.6 percentage points (the stock lost 5.1% while the market gained 20.5%) | -25.6% |
Signal agreement
2
| Bullish technical signals | 0 of the 9 technical signals we can compute for it are currently in a bullish state — these describe past price behaviour, not a forecast | 0 of 9 |
|---|---|---|
| Bearish technical signals | 6 of the 9 technical signals we can compute for it are currently in a bearish state: a strong downtrend, with sellers in control, a "death cross" — its 50-day average is below its 200-day, trading below its 200-day average, MACD momentum is negative, lagging the market over 6 months, trading below the Ichimoku cloud — these describe past price behaviour, not a forecast | 6 of 9 |
Trend (Ichimoku cloud)
1
| Vs the Ichimoku cloud | trading 0.4% below the Ichimoku cloud — a band drawn from where its own highs and lows sat up to 2026-07-16 and projected forward over today's price, the side traders read as an established downtrend, with the band above acting as the level that would have to be cleared. The band itself is moderate, spanning 2.3% of the share price. | -0.4% |
|---|
Volume-weighted price
2
| Vs this year’s average price paid | the price is 6% below the average price paid so far this year, so the typical buyer over that stretch is under water. That average is $78.00 — a volume-weighted average of daily closes over 157 sessions, not a true tick-by-tick VWAP. | -6.0% |
|---|---|---|
| Vs the average paid since it last reported | the price is 1% above the average price paid since it last reported on 2026-08-10 (its 10-Q), so the typical buyer over that stretch is showing a gain. That average is $72.37 — a volume-weighted average of daily closes over 10 sessions, not a true tick-by-tick VWAP. | +1.4% |
Price levels it has turned at before
NHI last closed at $73.36 on 2026-08-21. Since 2024-08-21 it has turned at 5 prices below its last close and 6 above; the 3 nearest below and the 3 nearest above are listed, nearest first.
| Level | Side | Distance | Evidence |
|---|---|---|---|
| $72.71 | Support | 0.9% below the last close | turned there 7 times · 2025-03-25 to 2026-06-11 |
| $75.13 | Resistance | 2.4% above the last close | turned there six times · 2024-10-21 to 2026-07-10 |
| $71.03 | Support | 3.2% below the last close | turned there six times · 2024-11-06 to 2025-10-13 |
| $77.50 | Resistance | 5.7% above the last close | turned there 12 times · 2024-11-19 to 2026-07-07 |
| $68.97 | Support | 6.0% below the last close | turned there 7 times · 2024-12-20 to 2026-08-11 |
| $78.88 | Resistance | 7.5% above the last close | turned there twice · 2025-05-06 to 2025-12-19 |
A level is a price this company reversed or paused at more than once — they describe past behaviour, not a forecast of where the price will go.
Wave structure
Its recent swings can be read as a five-part upward sequence — what Elliott-wave chartists call an impulse — now in leg 3 of five.
This labelling fails — stops being a possible reading at all — if it closes below $69.49.
This is one of several labellings that fit the same swings, so treat it as a reading rather than the reading. It was chosen from 2 labellings that survived the rules, counting shorter readings of the same bars.
On past moves of this shape the leg has usually ended somewhere between $82.84 and $91.09 — that is where it has tended to end if the count holds, not a forecast of where the price goes.
Alternate reading: The same swings also read as a three-part correction in leg C, which fails on a close below $69.49.
This reading has stood for 4 trading days, since 2026-08-18.
Read from daily closes as of 2026-08-21.
An Elliott-wave count describes the swings already printed and the level that would disprove it. It is not a forecast, a target, or advice.
Screens: Trading below the 200-day moving average · lagging the market · Trading below the Ichimoku cloud · Most technical signals bearish · Near a support level (sitting on a price it has bounced off before) · Elliott wave 3 candidates | Learn: moving average · golden cross · adx · rsi · breakout · fifty two week high low
Based on daily closing prices as of 2026-08-21. Describes past price behavior only — informational, not financial advice.
Analyst consensus
- Consensus ratingBuy (1.75 mean, 1=Strong Buy…5=Strong Sell) — 8 analysts
- Mean price target$82.13 range $73.00 – $90.00; median $80.50
Analyst estimates, as of 2026-08-23. These are third-party analyst opinions and price targets, aggregated — not a recommendation, prediction, or advice from stocks-llm. Informational only.
Analyst EPS estimate for NHI
- Consensus EPS estimate$4.57 next reporting period, as of 2026-08-23
Change over time is not available yet: it needs two readings of the same reporting period at least 30 days apart, and we have been recording these estimates since 2026-08-04. An estimate for a DIFFERENT quarter is not a revision, so a reading from before the last report is never compared with one after it.
The consensus estimate for the next reporting period, and how it has moved between readings of that SAME period. A change is measured only between readings estimating one period — when a company reports, the consensus moves to the next quarter and the two numbers are not comparable. Informational only, not a forecast and not advice.
Key risks (from latest filing)
["Reliance on the operational performance and financial stability of tenant operators.","Sensitivity to changes in interest rates and capital market conditions.","Regulatory and reimbursement risks associated with the healthcare and senior housing industries."]
What changed in the latest 10-Q
AI-assisted comparison of NHI's 10-Q filed 2026-05-04 against the prior one filed 2025-11-06.
Management's Discussion & Analysis (MD&A)
- Added:
- Added risk factor: 'We may be unable to replace our managers if the management agreements are terminated or not renewed' (2026-05-04)
- Added risk factor: 'Our use of artificial intelligence could expose us to various risks' (2026-05-04)
- Added language specifying 'rental income' instead of 'rent' in tenant concentration risk factor (2026-05-04)
- Added language 'business, financial condition and results of operations' in first risk factor, changing from 'financial condition and results of operations' (2026-05-04)
- Removed:
- Removed risk factor: 'We are exposed to risks associated with our investment in Timber Ridge OpCo, LLC ("Timber Ridge Opco"), including our lack of sole decision-making authority, our reliance on the financial condition of other interests and related healthcare operations of the entity' (2025-11-06)
- Removed risk factor: 'Settlement provisions contained in any forward sales agreements we may have entered into could result in substantial dilution to our earnings per share or result in substantial cash payment obligations' (2025-11-06)
- Removed risk factor: 'In case of our bankruptcy or insolvency, any forward sales agreements in effect will automatically terminate, and we would not receive the expected proceeds from such forward sales of shares of our common stock' (2025-11-06)
- Removed language 'Risks related to our joint venture investments could adversely affect our financial condition and results of operations' was listed separately; now consolidated differently (2026-05-04 vs 2025-11-06)
- Reworded:
- Changed 'we have entered into' to 'we might receive from cash settlement of our forward equity sales agreements' in forward sales tax treatment risk (2026-05-04)
- Changed 'forward sales agreements' to 'forward equity sales agreements' (2026-05-04)
- Changed 'cost and availability of capital' to 'costs and availability of capital' in credit ratings risk (2026-05-04)
- Changed 'future capital needs' to 'future capital needs,' with comma addition (2026-05-04)
- Changed 'our business and its information' to 'our business and its information' - cybersecurity risk factor wording refined (2026-05-04)
- Changed 'We may be unable to replace our managers' insertion shifts risk ordering in newer filing (2026-05-04)
- Changed 'increased market prices' to 'increased market prices' - competition risk factor wording (2026-05-04)
- Notes:
- Text appears truncated at end of both filings; comparison limited to available content
- Line numbering differs (36 vs 42-43) between filings, suggesting different section lengths
- Some risk factors may have been reordered rather than added/removed; cannot definitively confirm without full document context
Risk Factors
The two filings could not be meaningfully compared for this section.
AI-assisted comparison of two SEC filing sections. It describes wording and theme changes only, makes no materiality, legal, or investment judgement, and is not financial advice. Informational only — not financial advice.
Insider activity (SEC Form 4)
2 open-market purchases and 0 open-market sales by insiders in the last 90 days.
- Last 90 days2 buys ($167027) · 0 sells — 2 buying insiders
- Last 180 days2 buys ($167027) · 0 sells — 2 buying insiders
Activity heuristic: net buying (a transparent product heuristic from the counts above, not a prediction or advice)
Most recent open-market transaction: 2026-06-15. As of 2026-08-24.
View full insider trading history → View SEC Form 3/4/5 filingsAsk about NHI's insider activity →
Only open-market purchases (SEC code P) and sales (code S) are counted here. Option exercises, vesting/awards, gifts, and shares withheld for taxes are excluded — they are compensation or mechanical, not open-market conviction. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan) and are not necessarily bearish; open-market buying is not a recommendation to buy. Informational only — not financial advice.
Congressional trading disclosures
U.S. House members publicly disclose their own, their spouse's, and dependent children's stock transactions under the STOCK Act. We hold 1 matched disclosure for NHI from U.S. House Clerk Periodic Transaction Report filings.
Congressional trading disclosures →Short interest (FINRA)
NHI had 1,495,586 shares of reported short interest as of the 2026-07-31 FINRA settlement date (delayed, bi-monthly; not real-time).
NHI had 3.05% of its shares outstanding sold short as of the 2026-07-31 FINRA settlement date (percent of FLOAT would be higher — float is not disclosed in the source). FINRA reported 3.71 days to cover at the same settlement.
- Reported short interest (shares) 1,495,586
- Short interest (% of shares outstanding) 3.05%
- Prior settlement (shares) 2,094,689
- Reported change -28.6%
- Days to cover (reported) 3.71
Reported to FINRA as of the 2026-07-31 settlement date. Short interest is reported to FINRA and published on a delayed, bi-monthly schedule (as of a settlement date, disseminated roughly eight business days later) — it is NOT real-time, does not cover every venue or all US trading, and is not a short-squeeze prediction or investment advice. Days-to-cover is the value FINRA reports; percent of float is not shown because the source file carries no share-count denominator — where a percent appears it is of shares OUTSTANDING, the larger base, and is therefore a floor on percent of float. Informational only — not financial advice.
Competitors & peers
- Ventas (VTR)
- Welltower (WELL)
- Healthpeak Properties
- Omega Healthcare Investors (OHI)
- Sabra Health Care REIT (SBRA)
AI-enriched competitor set. Linked names are companies covered by stocks-llm; other named peers are shown for reference only.
Compare NHI vs…
NATIONAL HEALTH INVESTORS REIT INC is found in…
Frequently asked questions
What does NATIONAL HEALTH INVESTORS REIT INC (NHI) do?
National Health Investors is a real estate investment trust (REIT) that specializes in the financing and ownership of healthcare-related properties. The company maintains a portfolio that includes independent living facilities, assisted living facilities, skilled nursing facilities, and medical office buildings, primarily utilizing sale-leaseback transactions and mortgage financing.
What sector is NATIONAL HEALTH INVESTORS REIT INC (NHI) in?
NATIONAL HEALTH INVESTORS REIT INC (NHI) is classified in the Real Estate sector. Its industry is healthcare REITs. It trades on NYSE.
Does NHI pay a dividend?
Yes — NATIONAL HEALTH INVESTORS REIT INC (NHI) pays a dividend, with an indicated yield of about 6.63% and 2-year non-decreasing per-share dividend streak (SEC EDGAR XBRL) (market data, as of 2026-08-24). Informational only — not financial advice.
Who are NATIONAL HEALTH INVESTORS REIT INC's (NHI) competitors?
Notable peers of NATIONAL HEALTH INVESTORS REIT INC (NHI) include Ventas, Welltower, Healthpeak Properties, Omega Healthcare Investors and Sabra Health Care REIT. This peer set is informational only — not financial advice.
Has there been recent Congressional stock trading in NHI?
Yes — we hold 1 matched STOCK Act disclosure for NHI from U.S. House Clerk Periodic Transaction Report filings. These are legally-required disclosures (often filed 30–45 days after the trade), may belong to a U.S. House member, their spouse, or a dependent child, and are not an indicator of company performance or investment advice.
Is NATIONAL HEALTH INVESTORS REIT INC (NHI) overbought or oversold right now?
NATIONAL HEALTH INVESTORS REIT INC (NHI) is currently neither overbought nor oversold — its 14-day RSI (a 0–100 momentum gauge) is 44, in the neutral middle (as of 2026-08-21). RSI describes recent price momentum, not a forecast — informational only, not financial advice.
Where does stocks-llm's data on NHI come from?
Fundamentals and prices come from market data, as of 2026-08-24; company filings and profile facts come from SEC EDGAR. All figures are delayed daily-close data shown with their as-of date — informational only, not financial advice.
Fundamentals: market data, as of 2026-08-24. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-08-21.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date.